-
EP1009399
European procedure
Extract from the Register of European Patents
EP About this file: EP1009399
| EP1009399 - GABA ANALOGS TO PREVENT AND TREAT GASTROINTESTINAL DAMAGE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 28.01.2011 Database last updated on 02.11.2024 | Most recent event Tooltip | 03.05.2013 | Lapse of the patent in a contracting state | published on 05.06.2013 [2013/23] | Applicant(s) | For all designated states Warner-Lambert Company LLC 235 East 42nd Street New York, NY 10017 / US | For all designated states The Board of Regents for the University of Oklahoma 660 Parrington Oval, Evans Hall Room 100 Norman Oklahoma 73019 / US | [2010/12] |
| Former [2007/08] | For all designated states Warner-Lambert Company LLC 235 East 42nd Street New York, NY 10017 / US | ||
| For all designated states The Board of Regents for the University of Oklahoma 660 Parrington Oval, Evans Hall Room 100 Norman, Oklahoma 73019 / US | |||
| Former [2005/22] | For all designated states WARNER-LAMBERT COMPANY LLC 201 Tabor Road Morris Plains, NJ 07950 / US | ||
| For all designated states The Board of Regents for the University of Oklahoma 660 Parrington Oval, Evans Hall Room 100 Norman, Oklahoma 73019 / US | |||
| Former [2000/25] | For all designated states WARNER-LAMBERT COMPANY 201 Tabor Road Morris Plains New Jersey 07950 / US | ||
| For all designated states The Board of Regents for the University of Oklahoma 660 Parrington Oval, Evans Hall Room 100 Norman, Oklahoma 73019 / US | Inventor(s) | 01 /
GUGLIETTA, Antonio 623 Trego Circle Ann Arbor, MI 48103 / US | 02 /
TAYLOR, Charles, Price, Jr. 405 Madison Street Chelsea, MI 48118 / US | 03 /
REN, Jiayuan 8301 N.W. 112th Street Oklahoma City, OK 73162 / US | 04 /
WATSON, W. P. 9 Station Road Meadowfield, Durham DH7 8NF / GB | 05 /
RAFFERTY, Michael, Francis 3711 Rolling Ridge Court Ann Arbor, MI 48105 / US | 06 /
DIOP, Laurent 38, rue de Villeras Val d'Albian, 91400 Saclay / FR | 07 /
CHOVET, Maria 10, Villa du Cadran Solaire F-92120 Montrouge / FR | 08 /
BUENO, Lionel 1, chemin Laubarede F-31840 Aussonne / FR | 09 /
LITTLE, Hilary J. Field House, Bedburn Hamsterley, County Durham DL13 3NN / GB | [2000/25] | Representative(s) | Rudge, Andrew John, et al ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / FR | [N/P] |
| Former [2008/41] | Rudge, Andrew John, et al Pfizer Limited European Patent Department Ramsgate Road Sandwich CT13 9NJ / GB | ||
| Former [2006/18] | Rudge, Andrew John, et al Pfizer Limited European Pharma Patent Department Ramsgate Road Sandwich, Kent CT13 9NJ / GB | ||
| Former [2000/25] | Tesch, Rudolf, Dr., et al Warner-Lambert Company, Legal Division, Patent Department, Mooswaldallee 1 79090 Freiburg / DE | Application number, filing date | 98945758.5 | 18.08.1998 | [2000/25] | WO1998US17082 | Priority number, date | US19970056753P | 20.08.1997 Original published format: US 56753 P | US19980074794P | 16.02.1998 Original published format: US 74794 P | US19980082936P | 24.04.1998 Original published format: US 82936 P | [2000/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9908671 | Date: | 25.02.1999 | Language: | EN | [1999/08] | Type: | A1 Application with search report | No.: | EP1009399 | Date: | 21.06.2000 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.02.1999 takes the place of the publication of the European patent application. | [2000/25] | Type: | B1 Patent specification | No.: | EP1009399 | Date: | 24.03.2010 | Language: | EN | [2010/12] | Search report(s) | International search report - published on: | EP | 25.02.1999 | Classification | IPC: | A61K31/195, A61P1/00 | [2009/44] | CPC: |
A61K31/42 (EP,US);
A61K31/195 (EP,KR,US);
A61K31/197 (EP,US);
A61K31/40 (EP,US);
A61K31/405 (EP,US);
A61K31/54 (EP,US);
A61K31/60 (EP,US);
A61K45/06 (EP,US);
A61P1/00 (EP);
| C-Set: |
A61K31/195, A61K2300/00 (US,EP);
A61K31/195, A61K31/19 (US,EP);
A61K31/195, A61K31/195 (US,EP);
A61K31/405, A61K2300/00 (EP,US);
A61K31/405, A61K31/195 (US,EP);
A61K31/40, A61K2300/00 (US,EP);
A61K31/40, A61K31/195 (US,EP);
A61K31/42, A61K2300/00 (EP,US);
A61K31/42, A61K31/195 (US,EP);
A61K31/54, A61K2300/00 (EP,US);
A61K31/54, A61K31/195 (US,EP);
A61K31/60, A61K2300/00 (US,EP); |
| Former IPC [2000/25] | A61K31/195 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/25] | Extension states | AL | 20.03.2000 | LT | 20.03.2000 | LV | 20.03.2000 | MK | 20.03.2000 | RO | 20.03.2000 | SI | 20.03.2000 | Title | German: | GABA-ANALOGA ZUR VERHÜTUNG UND BEHANDLUNG GASTROINTESTINALER BESCHWERDEN | [2009/44] | English: | GABA ANALOGS TO PREVENT AND TREAT GASTROINTESTINAL DAMAGE | [2000/25] | French: | ANALOGUES DU GABA POUR PREVENIR ET TRAITER DES LESIONS GASTRO-INTESTINALES | [2000/25] |
| Former [2000/25] | GABA-ANALOGEN ZUR VERHÜTUNG UND BEHANDLUNG GASTROINTESTINALER BESCHWERDEN | Entry into regional phase | 20.03.2000 | National basic fee paid | 20.03.2000 | Designation fee(s) paid | 20.03.2000 | Examination fee paid | Examination procedure | 16.02.1999 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 20.03.2000 | Examination requested [2000/25] | 02.09.2002 | Despatch of a communication from the examining division (Time limit: M06) | 04.03.2003 | Reply to a communication from the examining division | 14.07.2003 | Despatch of a communication from the examining division (Time limit: M06) | 16.01.2004 | Reply to a communication from the examining division | 10.03.2005 | Despatch of a communication from the examining division (Time limit: M06) | 16.09.2005 | Reply to a communication from the examining division | 30.05.2006 | Despatch of a communication from the examining division (Time limit: M04) | 29.09.2006 | Reply to a communication from the examining division | 27.11.2007 | Despatch of a communication from the examining division (Time limit: M02) | 25.01.2008 | Reply to a communication from the examining division | 04.11.2009 | Communication of intention to grant the patent | 10.02.2010 | Fee for grant paid | 10.02.2010 | Fee for publishing/printing paid | Opposition(s) | 28.12.2010 | No opposition filed within time limit [2011/09] | Fees paid | Renewal fee | 31.08.2000 | Renewal fee patent year 03 | 31.08.2001 | Renewal fee patent year 04 | 02.09.2002 | Renewal fee patent year 05 | 25.08.2003 | Renewal fee patent year 06 | 23.08.2004 | Renewal fee patent year 07 | 31.08.2005 | Renewal fee patent year 08 | 07.08.2006 | Renewal fee patent year 09 | 03.08.2007 | Renewal fee patent year 10 | 08.08.2008 | Renewal fee patent year 11 | 31.08.2009 | Renewal fee patent year 12 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MC | 31.08.2010 | [2013/23] |
| Former [2011/35] | MC | 31.08.2010 | |
| Former [2011/28] | IT | 18.08.2010 | |
| MC | 31.08.2010 | Cited in | International search | [A]WO9611680 (GLAXO GROUP LTD [GB], et al) [A] 1-16 * page 1, line 24 - line 34 * * page 3, line 8 * * page 3, line 11 - line 16 *; | [XP]WO9811885 (ASTRA AB [SE], et al) [XP] 1-3,10 * page 2, line 11 - line 13 * * page 3, line 16 - line 18 * * page 4, line 13 *; | [XP]WO9817627 (WARNER LAMBERT CO [US], et al) [XP] 1,10,11 * page 11, line 14 - line 19 * * page 2; figure I *; | [XP] - LESCH ET AL, "the gaba-derivative 3-isobutyl gaba acts centrally to protect against indomethacin-induced gastric damage in rats", GASTROENTEROLOGY, (19980415), vol. 114, no. 4, page 200, XP002081396 [XP] 1,5-7,9,12,15-17,20-23 * abstract * DOI: http://dx.doi.org/10.1016/S0016-5085(98)80815-9 | [XP] - REN ET AL, "effects of gabapentin on indomethacin-induced and ethanol-induced gastric injury", GASTROENTEROLOGY, (19980415), vol. 114, no. 4, page 267, XP002081397 [XP] 1-3,9,12-14,17-19,22,23 * abstract * |